Results 51 to 60 of about 5,322 (214)
Avaliação colonoscópica em pacientes com espondilite anquilosante
Revista Brasileira de Reumatologia, 2014 Introdução: Pacientes com espondilite anquilosante podem apresentar-se com lesões inflamatórias intestinais, e, por isso, deve ser definido o uso da colonoscopia para tais pacientes.
Haim Cesar Maleh +4 more
doaj +1 more source
Increasing smoking intensity is associated with increased disease activity in axial spondyloarthritis. [PDF]
, 2016 A history of ever-smoking appears to be associated with a more severe disease phenotype in axial spondyloarthritis (axSpA). However, evidence is sparse for the effect of increased smoking exposure on disease outcomes or whether smoking reduction or ...
Challoner, B +4 more
core +1 more source
BMC Musculoskeletal Disorders, 2017 Background Previously, many studies have evaluated quality of life (QoL) in patients with ankylosing spondylitis (AS), however, none of them specifically investigated the correlation between pain-related disability measured by Oswestry Disability Index ...
Ji-chen Huang +7 more
doaj +1 more source
Patient-reported outcomes in European spondyloarthritis patients: a systematic review of the literature [PDF]
, 2018 Objective: This review aims to summarize the current literature on patient-reported outcomes (PROs) in spondyloarthritis (SpA). Patients and methods: We performed a systematic literature review to identify studies (original articles and narrative and ...
Blanch, Carles +4 more
core +2 more sources
Prevalence of fibromyalgia in patients with ankylosing spondylitis
Medical Journal of Dr. D.Y. Patil University, 2014 Introduction: Ankylosing spondylitis (AS) is a chronic inflammatory disease that affects the peripheral and axial skeletal system, causing pain, arthritis, low back pain and functional incapacity.
Aref Hosseinian Amiri, Omid Sedighi
doaj +1 more source
A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis [PDF]
, 2010 The signs and symptoms of ankylosing spondylitis (AS) respond inadequately to nonsteroidal antiinflammatory drugs, corticosteroids, and disease modifying antirheumatic drugs in quite a number of patients.
Ciccia, F. +6 more
core +1 more source
Arthritis &Rheumatology, Volume 77, Issue 6, Page 658-663, June 2025.Objective In rheumatoid arthritis (RA) and spondyloarthritis (SpA), managing persistent pain remains challenging. Little is known regarding impaired pain pathways in these patients and the impact of biologic disease‐modifying antirheumatic drugs (bDMARDs).
Anne‐Priscille Trouvin +9 more
wiley +1 more source
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study [PDF]
, 2017 AIM To report adalimumab (Ada) efficacy on articulargastrointestinal disease and health-related quality of life (HRQoL) in patients with enteropathic spondyloarthritis (ES).
Benfaremo, D. +9 more
core +1 more source
International Journal of Rheumatic Diseases, Volume 28, Issue 5, May 2025.ABSTRACT Aim The objective was to evaluate biologic disease‐modifying antirheumatic drugs (DMARDs) and their side effects that hindered the continuation of treatment in a patient population diagnosed with spondyloarthritis (SpA) with a glomerular filtration rate (GFR) ≤ 60 mL/min, and to compare these side effects between patients with chronic kidney ...
Dilara Bulut Gökten +23 more
wiley +1 more source
Effect of food intake and ambient air pollution exposure on ankylosing spondylitis disease activity
Advances in Rheumatology, 2019 Background Ankylosing spondylitis (AS) is a chronic inflammatory disease characterized by axial arthritis. The genetic–environmental factors seem to be involved in the pathogenesis of the disease and the disease debilitates patients during the most ...
Narjes Soleimanifar +7 more
doaj +1 more source